Michael John Ackerman, MD, PhD, FACC

  • 37032 Citations
  • 106 Scopus h-Index
1991 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Comment/debate
2015

Hypertrophic cardiomyopathy, athlete's heart, or both: A case of hypertrophic cardiomyopathy regression

Kebed, K. Y., Bos, J. M., Anavekar, N. S., Mulvagh, S. L., Ackerman, M. J. & Ommen, S. R., May 1 2015, In : Circulation: Cardiovascular Imaging. 8, 7, e003312.

Research output: Contribution to journalComment/debate

2 Scopus citations

MY APPROACH to treatment of the congenital long QT syndromes

Ackerman, M. J., Jan 1 2015, In : Trends in cardiovascular medicine. 25, 1, p. 67-69 3 p.

Research output: Contribution to journalComment/debate

8 Scopus citations
2013

Azithromycin and risk of sudden cardiac death: Guilty as charged or falsely accused

Giudicessi, J. R. & Ackerman, M. J., Sep 1 2013, In : Cleveland Clinic journal of medicine. 80, 9, p. 539-544 6 p.

Research output: Contribution to journalComment/debate

18 Scopus citations
2012

Erratum: HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies (Europace (2011) 13 (1077-1109) DOI: 10.1093/europace/eur245)

Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., Camm, A. J., Ellinor, P. T., Gollob, M., Hamilton, R., Hershberger, R. E., Judge, D. P., Le Marec, H., McKenna, W. J., Schulze-Bahr, E., Semsarian, C., Towbin, J. A., Watkins, H., Wilde, A., Wolpert, C. & 1 others, Zipes, D. P., Feb 1 2012, In : Europace. 14, 2, 1 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2010

Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy

Landstrom, A. P. & Ackerman, M. J., Dec 7 2010, In : Circulation. 122, 23, p. 2441-2449 9 p.

Research output: Contribution to journalComment/debate

99 Scopus citations

Response to Ho

Landstrom, A. P. & Ackerman, M. J., Dec 7 2010, In : Circulation. 122, 23, 1 p.

Research output: Contribution to journalComment/debate

2009

Response to Elliott and McKenna

Maron, B. J., Seidman, C. E., Ackerman, M. J., Towbin, J. A., Maron, M. S., Ommen, S. R., Nishimura, R. A. & Gersh, B. J., Feb 1 2009, In : Circulation: Cardiovascular Genetics. 2, 1, 1 p.

Research output: Contribution to journalComment/debate

What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy

Maron, B. J., Seidman, C. E., Ackerman, M. J., Towbin, J. A., Maron, M. S., Ommen, S. R., Nishimura, R. A. & Gersh, B. J., Feb 1 2009, In : Circulation: Cardiovascular Genetics. 2, 1, p. 81-85 5 p.

Research output: Contribution to journalComment/debate

42 Scopus citations
2008

A mutation in telethonin alters Nav1.5 function (Journal of Biological Chemistry (2008) 283 (16537-16544))

Mazzone, A., Strege, P. R., Tester, D. J., Bernard, C. E., Faulkner, G., De Giorgio, R., Makielski, J. C., Stanghellini, V., Gibbons, S. J., Ackerman, M. J. & Farrugia, G., Aug 8 2008, In : Journal of Biological Chemistry. 283, 32, 1 p.

Research output: Contribution to journalComment/debate

2005

Genetic testing for cardiac channelopathies: Ten questions regarding clinical considerations for heart rhythm allied professionals

Tester, D. J. & Ackerman, M. J., Jun 1 2005, In : Heart rhythm. 2, 6, p. 675-677 3 p.

Research output: Contribution to journalComment/debate

26 Scopus citations
2003

Sudden unexplained death: Evaluation of those left behind

Lee, A. & Ackerman, M. J., Nov 1 2003, In : Lancet. 362, 9394, p. 1429-1431 3 p.

Research output: Contribution to journalComment/debate

11 Scopus citations